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Abstract 
 
Background/Aim. Data on phytochemical and pharmacolo-
gical investigations of genus Cirsium Mill. (Asteraceae) are scar-
ce. Some data suggest that decoctions or infusions prepared 
from these plants are used in folk medicine as tonics, 
particularly in inflammatory, liver and stomach diseases. So far 
there have been no pharmacological investigations related to 
Cirsium ligulare (C. ligulare) Boiss. Accordingly, the aim of this 
study was to estimate antioxidative, anti-inflammatory and gas-
troprotective activities of aqueous extracts of C. ligulare herb 
prepared as 5% and 10% decoctions. Methods. Antioxidative 
activity was determined using the method of 2,2-diphenyl-1-
picrylhydrazyl (DPPH) radical scavenging. Investigations of 
anti-inflammatory (a model of systemic inflammatory response 
induced by endotoxin of Escherichia coli and carrageenan-
induced rat paw oedema model for local inflammatory respon-
se), as well as gastroprotective effects (a model of stress-ulcer 
induced by absolute ethanol), were conducted in adult female 
Wistar rats that were given the aqueous extracts of C. ligulare 
herb per os. Indomethacin and ranitidine were used as reference 
drugs for evaluation of local anti-inflammatory and gastropro-
tective effects, respectively. Results. The results demonstrated 
that aqueous extracts of C. ligulare herb produced strong 
antioxidative activity, diminished body weight loss induced by 
endotoxin, significantly reduced carrageenan-induced paw 
oedema, and prevented the ulcerogenic action of absolute 
ethanol. Both anti-inflammatory and gastroprotective activi-
ties of the extract tested were comparable to those of the re-
ference drugs. Conclusion. Presented results justify the tradi-
tional use of C. ligulare herb decoctions and further 
phytochemical and pharmacological investigations are 
warranted. 
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Apstrakt 
 
Uvod/Cilj. Biljke roda Cirsium su hemijski i farmakološki 
nedovoljno ispitane. Tradicionalno se dekokti ili infuzi ovih 
biljaka koriste kao tonici, naročito kod zapaljenjskih 
procesa, kao i kod bolesti jetre i želuca. Vrsta Cirsium ligulare 
(C. ligulare) Boiss. do sada nije farmakološki ispitivana. Stoga 
je cilj ovog istraživanja bio da se proceni antioksidantna, an-
tiinflamatorna i gastroprotektivna aktivnost vodenog ek-
strakta herbe C. ligulare izrađenog kao 5% i 10% dekokt. 
Metode. Ispitivanje antioksidantne aktivnosti vršeno je tes-
tom neutralizacije 2,2-diphenyl-1-picrylhydrazyl (DPPH) 
radikala. Ispitivanje antiinflamatornog (model sistemskog in-
flamatornog odgovora indukovan endotoksinom bakterije 
Escherichia coli i karageninom-indukovani edem šape pacova 
kao model lokalne inflamcije), kao i gastroprotektivnog 
efekta (model ulkusa indukovanog apsolutim etanolom), 
sprovedeno je na odraslim ženkama pacova Wistar soja, ko-
jima su per os dati vodeni ekstrakti herbe C. ligulare. Kao ref-
erentni lekovi prilikom ispitivanja lokalnog antiinflamator-
nog i gastroprotektivnog delovanja, primenjeni su indo-
metacin i ranitidin, redom. Rezultati. Rezultati pokazuju da 
su ispitivani vodeni ekstrakti herbe C. ligulare ispoljili jaku 
antioksidantnu aktivnost, smanjili gubitak telesne mase in-
dukovan endotoksinom, značajno redukovali karageninom 
indukovani edem šape pacova i spečili ulcerogeni efekat ap-
solutnog etanola. Antiinflamatorna i gastroprotektivna ak-
tivnost ispitivanih ekstrakata bila je uporediva sa aktivnošću 
referentnih lekova. Zaključak. Dobijeni rezultati u značajnoj 
meri opravdavaju tradicionalnu primenu dekokta herbe C. lig-
ulare, a planiraju se i dodatna hemijska i farmakološka ispiti-
vanja ove droge. 
 
Ključne reči: 
cirsium; asteraceae; farmakološka dejstva; medicina, 
biljna; pacovi, wistar. 
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Introduction  
Genus Cirsium Mill. (Asteraceae) includes about 120 spe-
cies widely distributed in Europe, North Africa, West and North 
Asia, as well as North and Central America 1. According to avai-
lable data, these species contain flavonoids 2–4, phenolic acids, 
essential oils, sterols, triterpenes, as well as alkaloids, 
polyacetylenes, hydrocarbons, aliphatic aldehydes and guaiano-
lides–sesquiterpene lactones 5, 6. Traditionally, they are used as 
tonics, antiphlogistics, diuretics, diaphoretics, adstringents and 
venoactive remedies 6, 7, as well as anti-hemorrhagic, diuretic 
and anticancer agents 4, against a cough and peptic ulcers 8. 
Cirsium ligulare (C. ligulare) Boiss. is one of 22 Cirsium 
species present in the Serbian flora 9. In folk medicine of Serbia 
and Montenegro, according to our ethnomedicinal experience, 
decoctions or infusions prepared from its herb are used as tonics, 
particularly in inflammatory, liver and stomach complaints. 
However, data on C. ligulare research are scarce. Chlorogenic 
acid and flavonoids (apigenin, apigenin 7-glucoside, kaempferol 
3-glucoside and kaempferol 3-rhamnoglucoside) were identified 
in methanolic extracts of C. ligulare leaves and inflorescences 2. 
In the essential oil of its inflorescence, beside predominant alip-
hatic hydrocarbons, small amounts of thymol (2.4%), eugenol 
(0.6%) and carvacrol (0.3%) were present 5. To the best of our 
knowledge, no pharmacological investigations of this species 
have been conducted. 
Thus, the aim of this study was to estimate 
antioxidative, anti-inflammatory and gastroprotective activi-
ties of aqueous extracts of C. ligulare herb, prepared in the 
traditional manner as decoctions. 
Methods 
Chemicals 
Dimethylsulfoxide (DMSO), 2,2-diphenyl-1-picrylhydrazyl, 
lipopolysaccharides (LPS) from Escherichia coli 0128:B8 
(Cat. No L3880) and indomethacin were obtained from Sig-
ma Chemical Co. (St. Louis, USA); absolute ethanol (96%, 
v/v) from Merck (Darmstadt, Germany); L-ascorbic acid 
from Lachema (Neratovice, Czech Republic); rutin from 
Roth (Karlsruhe, Germany), and ranitidine from Zdravlje-
Actavis Company (Leskovac, Serbia). 
Plant material 
The herb of C. ligulare was collected in summer 2004 
from natural habitat in the river Lim valley, close to its spring 
from Plavsko lake (North-Eastern region of Montenegro). Once 
harvested, the plant material was dried at room temperature. It 
was identified by Prof. P. Marin, PhD (Institute of Botany, 
Faculty of Biology, University of Belgrade, Serbia). 
Preparation of decoctions 
Prior to extraction, the plant material was reduced to a 
coarse powder. Decoctions were prepared by boiling 5.0 and 
10.0 g of powdered material in 100 mL of distilled water for 
5 min to prepare 5 and 10% (w/v) decoctions. After 10 min, 
the extracts were allowed to cool at room temperature and 
filtered. Extracted plant material was washed with distilled 
water and the volume of the prepared decoctions was adjus-
ted to 100 mL using these washings. Decoctions were each 
time prepared ex tempore. 
Animals 
Adult female Wistar rats, weighing 200–250 g, were 
used in the experiments in which anti-inflammatory and anti-
ulcer activities of decoctions of C. ligulare were tested. Be-
fore the experiments, the animals were housed in groups of 5 
to a plastic cage in standard laboratory condition (room tem-
perature of 22 ± 1 ºC, 30% humidity, 12/12 h light/dark 
cycle) with free access to food and tap water. Animal studies 
were conducted in accordance with the internationally accep-
ted principles for laboratory animal use and care in the Euro-
pean Community (EEC Directive of 1986; 86/609/EEC) 
adopted by Ethical Committee of Military Medical 
Academy, Belgrade. 
Antioxidant activity (DPPH radical assay) 
Four milliliters of 5% decoction of the drug, prepared 
as described above, was mixed with 1 mL of 0.5 mM DPPH 
in methanol, and final volume was adjusted up to 5 mL. The 
mixture was vigorously shaken and left 30 min in dark. Ab-
sorbance was measured at 517 using methanol as blank. One 
milliliter of 0.5 mM DPPH diluted with 4 mL of methanol 
was used as a control. Scavenging (SC) of DPPH radical was 
calculated using the equation: 
SC(%)=100×(A0-As)/A0 (1) 
A0 - the absorbance of the control (containing all rea-
gents except the test compound); As - the absorbance of the 
tested sample. 
The SC50 value represents the concentration of the sam-
ple that caused 50% of DPPH radical scavenging. The relati-
ve activity of the samples was compared to those of L-
ascorbic acid and rutin 10. 
Anti-inflammatory activity 
Lipopolysaccharide (LPS)-induced systemic inflammatory 
response 
A systemic inflammatory reaction was induced by s.c. 
injection of LPS given in a dose of 5 mg/kg. This dose was 
chosen as a non-lethal one, but sufficient for producing a 
systemic inflammatory response, on the basis of previously 
performed experiments in which the LD50 of LPS for this 
species and this route of administration had been established 
(approximately 20 mg/kg). 
Before the experiments, the animals were divided into 
six groups of 15 rats in each, and their body mass, as well as 
the average consumption of food and water were determined. 
After that, they were given following treatments: 
Group 1 – intact controls drinking tap water; Group 2 – 
animals drinking 5% decoction of C. ligulare herb Group 3 – 
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animals drinking 10% decoction of C. ligulare herb; Group 4 
– animals injected by 5 mg/kg s.c. of LPS and drinking tap 
water; Group 5 – animals injected by 5 mg/kg s.c. of LPS 
and drinking 5% decoction of C. ligulare herb; Group 6 – 
animals injected by 5 mg/kg s.c. of LPS and drinking 10% 
decoction of C. ligulare herb. 
The experiment lasted 30 days after injecting LPS and, 
during this period, tap water or extracts (5 and 10% decocti-
ons of C. ligulare herb) were given to animals ad libitum. 
The body mass and consumption of food and water or the 
extract were measured each day, always at the same time (9 
a.m.). 
Carrageenan-induced rat paw oedema test 
The carrageenan-induced rat paw oedema was used as 
an experimental model of local inflammatory reaction as re-
ported earlier 11. 
The experimental groups consisted of 6–8 animals 
each. In order to estimate an anti-inflammatory activity of 
an aqueous extract of C. ligulare herb, the animals were gi-
ven 10% decoction of C. ligulare herb instead tapping 
water for seven days. On the day 8 of the experiment, a lo-
cal inflammatory reaction was induced by the injection of 
0.1 mL of carrageenan-saline solution (0.5%, w/v) into the 
plantar surface of the right hind paw of the rat. A saline 
was injected in a volume of 0.1 mL into the plantar surface 
of the left hind paw that served as the control (non-
inflamed) paw. The animals were sacrificed 3 h after the 
carrageenan and saline injections and paws were cut off for 
weighing. The difference in weight between right and left 
paw (in mg) served as an indicator of the inflammatory res-
ponse intensity (i.e. extent of the oedema). The control 
animals, instead of decoction, were drinking tap water for 
seven days before inducing paw oedema. The positive con-
trol group consisted of the animals treated with the well-
known non-steroidal anti-inflammatory drug (NSAID) in-
domethacin, dissolved in DMSO and given in a dose of 2 
mg/kg p.o. 60 min prior to injection of carrageenan soluti-
on. This dose of indomethacin reduced the carrageenan-
induced rat paw oedema by approximately 50%, as had 
shown in previously performed pilot-experiment. 
Effects of the treatments applied were estimated regarding 
the differences in rat paw oedema extent, i.e. intensity of 
inflammatory response, between the experimental groups. The 
difference in weight between right and left paw, active drug (de-
coct or indomethacin)-treated versus tap water (vehicle)-treated 
rats (the control group), served as an indicator of the anti-
inflammatory activity of drugs tested (the extract and indomet-
hacin). The inflammatory response was calculated using the 
equation: 
 
e Inflammatory response (%) = 
c 
100 (2) 
e – the difference in the paw weight in the active 
drug/treatment groups; c – difference in the paw weight in 
the control groups. 
Gastroprotective activity 
 
In order to study the anti-ulcer activity of decoction of C. 
ligulare herb an experimental model of acute gastric mucosal 
damage induced by absolute ethanol (1 mL/rat p.o.) was used. 
The experimental groups consisted of 6-8 animals each. 
For seven days the animals were given 10% decoction of C. 
ligulare herb instead of tap water, while the control animals 
were given tap water all the time. On the day 8 after the be-
ginning of the experiment the animals were given 1 mL of 
absolute ethanol through the gastric tube (the animals were 
starved at least 18 h before giving ethanol). Animals in the 
positive control group were treated by a single dose of raniti-
dine (20 mg/kg p.o.), the well-known anti-ulcer drug, given 
60 min prior the absolute ethanol. This dose of ranitidine was 
chosen as a proven anti-ulcer dose on the basis of previously 
performed pilot-experiment. 
The animals were sacrificed 1 h after ethanol administra-
tion, their stomachs removed and opened along the great cur-
vature. Lesions were examined under an illuminated magnifier 
(3×). The intensity of gastric lesions was assessed in accordan-
ce with a modified scoring system of Adami et al. 12. 
Results 
Antioxidative activity 
Antioxidative activity of 5% decoction of C. ligulare 
herb was determined using the method of DPPH radical sca-
venging, and the results are presented in Table 1.The anti-
DPPH activity of investigated decoction was comparable 
with the activity of vitamin C and rutin. 
Table 1 
Antioxidative activity of Cirsium ligulare  
herb decoction 
Sample tested SC50 
5% decoction of the C. ligulare herb 8.44 ± 1.17
L-ascorbic acid 4.09 ± 0.08
Rutin 5.75 ± 0.18
SC50 – concentration of the sample that caused 50% of 2,2-
difenil-1-picrylhydrazyl (DPHH) radical scavenging. 
Anti-inflammatory activity 
Results of LPS-induced systemic inflammatory response 
experiment are presented in Table 2. In our experimental condi-
tions, main changes were caused by LPS dose of 5 mg/kg s.c. 
related to the changes in body mass of treated animals. Namely, 
LPS led to the significant decrease of body mass gain in rats 
compared to the intact controls, particularly in the first two 
weeks after its injection. Reduced body mass in these animals 
was maintained during the whole period of observation. The 
usage of decoctions prepared from C. ligulare herb in both con-
centrations alleviated body mass decrease just within the first 
two weeks of the experiment when the body mass decrease in-
duced by LPS was the most pronounced. 
In the model of carrageenan-induced rat paw oedema, 
the 10% decoction of C. ligulare herb also produced a signi-
ficant anti-inflammatory effect (Table 3). Results of this 
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Table 2 
Influence of Cirsium ligulare herb decoctions on body mass changes (% of basal values) in rats with  
lipopolysaccharide induced systemic inflammatory response  
Days Treatment 7 14 21 28 
Group 1 16.81 ± 1.08 32.74 ± 1.95 40.7 ± 2.07 53.1 ± 2.21 
Group 2 14.83 ± 1.42 23.81 ± 1.89 36.74 ± 1.85 49.1 ± 1.97 
Group 3 12.56 ± 1.15 22.76 ± 1.72 32.56 ± 2.31 47.51 ± 2.18 
Group 4 - 0.62 ± 0.9a, b 6.26 ± 0.58a, b 21.52 ± 1.46a 27.8 ± 1.79a, b 
Group 5 2.12 ± 0.24a, b 13.34 ± 1.4a, c 25.56 ± 1.67a 31.8 ± 1.23a, b 
Group 6 2.23 ± 0.21a, b 14.65± 1.42a,c 27.25 ± 2.1a 31.5 ± 1.17a,b 
Group 1 – intact controls given tap water; Group 2 – animals given 5% decoction of C. ligulare herb; Group 3 – ani-
mals given 10% decoction of C. ligulare herb; Group 4 – animals injected by 5 mg/kg sc of lipopolysaccharide (LPS) 
and given tap water; Group 5 – animals injected by 5 mg/kg sc of LPS and given 5% decoction of C. ligulare herb; 
Group 6 - animals injected by 5 mg/kg sc of LPS and given 10% decoction of C. ligulare herb 
ap < 0.05 vs Group 1; bp < 0.05 vs Groups 2 and 3; cp < 0.05 vs Group 4. 
 
 
Table 3 
Influence of Cirsium ligulare herb decoction on the carrageenan- 
induced paw oedema (local inflammatory response) in rats 
Treatment Inflammatory response (%) 
None (the control group) 100.00 ± 25.98 
10% decoction of C. ligulare herb 70.05 ± 9.02a 
Indomethacin* (2 mg/kg p.o.) 59.15 ± 7.09b 
 *Reference drug; ap < 0.05; bp < 0.01 vs the control group. 
 
 
Table 4  
Influence of Cirsium ligulare herb decoction on the ethanol-induced acute stress-ulcer in rats 
Treatment Intensity of gastric lesions** 
None (the control group) 5.90 ± 1.14 
10% decoction of C. ligulare herb 2.26 ± 1.10a 
Ranitidine* (20 mg/kg p.o.) 1.77 ± 1.08a 
*Reference drug; ap < 0.01 vs the control group 
**0 = no lesions; 0.5 = slight hyperaemia or  5 petechiae; 1 =  5 erosions  5 mm in lenght; 1.5 =  5 ero-
sions  5 mm in lenght and many petechiae; 2 = 6–10 erosions  5 mm in lenght; 2.5 = 1–5 erosions > 5 mm 
in lenght; 3 = 5–10 erosions > 5 mm in lenght; 3.5 = >10 erosions > 5 mm in lenght; 4 = 1–3 erosions  5 mm 
in lenght and 0.5-1 mm in width; 4.5 = 4–5 erosions  5 mm in lenght and 0.5–1 mm in width; 5 = 1–3 ero-
sions > 5 mm in lenght and 0.5-1 mm in width; 6 = 4 or 5 grade 5 lesions; 7 =  6 grade 5 lesions; 8 = com-
plete lesion of the mucosa with haemorrhage (according to Adami et al. 12). 
 
experiment clearly demonstrate that 7-day drinking of the 10% 
decoction of C. ligulare herb produced significant anti-
inflammatory effect comparable to that of indomethacin, a 
strong NSAID, given in a dose of 2 mg/kg which corresponded 
to its ED50 (the dose that reduced the carrageenan-induced rat 
paw oedema by approximately 50%). However, post-mortem 
examination of the stomach of treated animals, revealed no 
changes in gastric mucosa in animals drinking the 10% decocti-
on of C. ligulare herb, while those given indomethacin had so-
me gastric lesions, mostly hyperaemia and petechiae. 
Gastroprotective activity 
The results of the present study demonstrated that 7-day 
use of the 10% decoction of C. ligulare herb significantly re-
duced the ulcerogenic effect of absolute ethanol in rats. More-
over, this effect was comparable to that achieved by a single 
dose of ranitidine, a well-known anti-ulcer drug (Table 4). 
Discussion 
Antioxidative activity 
 
The method of DPPH radical neutralization is often used for 
preliminary estimation of the antioxidative potential of various 
compounds because it is simple and provides a screening of 
antioxidative activities of a number of samples in a very short pe-
riod of time. Each substance with SC50 value ≤ 50 µg/mL is con-
sidered as a very strong antioxidant. The values of SC50 between 
50–100 µg/mL, also imply satisfactory antioxidative activity 13, 14. 
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Our preliminary chemical investigations on C. ligulare 
herb decoction have shown the presence of flavonoids (e.g. 
rutin and isoquercitrin) and phenolic acids (e.g. chlorogenic 
and rosmarinic acid) (unpublished data). This is partially in 
line with results presented earlier by Kozyra et al. 2. Since 
many flavonoids and phenolic acids are proven to be strong 
anti-DPPH scavengers 15, 16, presence of the above mentioned 
compounds could partly explain the obtained strong DPPH 
scavenging activity (Table 1). 
 
Anti-inflammatory activity 
 
For studying an anti-inflammatory activity of aqueous 
extracts of C. ligulare herb, two experimental models of 
inflammatory reaction were used. The first one was based on 
producing a systemic inflammatory response by the use of 
LPS, a major component of the outer membrane of Gram-
negative bacteria, which acts as the typical endotoxin. LPS 
binds the CD14/TLR4/MD2 receptor complex which acts as 
a promoter of the proinflammatory cytokines secretion in 
many cells, particularly in macrophages. In animals non-
lethal doses of LPS induce multisystemic responses that are 
manifested as changes in secretion of pituitary-hypophyse-
adrenal axis hormones, changes in body temperature and 
body mass, changes in normal sleeping cycle, etc. 17–20. As 
expected, LPS led to the significant decrease of body mass 
gain in rats during the whole period of the experiment. Tho-
ugh both decoctions alleviated body mass decrease within 
the first two weeks of the experiment, in the last two weeks 
everyday-drinking of the aqueous extract of the C. ligulare 
herb failed to influence the body mass gain in animals with 
LPS-induced inflammatory reaction. On the other hand, the 
extracts themselves did not significantly influence the body 
mass gain in intact animals. Contrary to the changes in body 
mass, there were no changes in consumption of food and 
drink in any of the experimental groups during the 
experiment. This finding implies an absence of anorectic ef-
fect of LPS and suggests that decrease of body mass gain in 
animals given LPS might be the consequence of its harmful 
effect on utilization of nutritive substances. It has been 
shown that LPS causes gut mucosal injury 19 that might be 
the reason of poor intestinal absorption of nutritive substan-
ces. If this assumption is correct it could mean that the 
aqueous extracts of C. ligulare herb tested may at least partly 
reduce this injury and, consequently, improve absorption of 
nutritive components from food. 
The model of carrageenan-induced rat paw oedema is 
often used for estimating the anti-inflammatory activity of 
various substances. It is known that injection of carrageenan 
in rat paw produces an acute local inflammatory response 
consisting of two phases. During the first hour after injection 
of carrageenan (the early phase) many vasoactive substances 
including bradykinins, prostaglandins, histamine, and 5-
hydroxytryptamin, are released. The second phase is charac-
terized by neutrophil infiltration, as well as by the additional 
production of prostaglandins 21–23. 
Since the production of prostaglandins is the key factor 
involved in both phases of carrageenan-induced inflammati-
on it might be proposed that the anti-inflammatory effect of 
the decoction of C. ligulare herb may be the consequence of 
the inhibition of synthesis and/or release of these arachidonic 
acid metabolites. Currently, no data about such an effect of 
the extract exist. However, during the second phase of carra-
geenan-induced acute inflammation induced, a great amount 
of free radical species are produced by activated 
polymorphonuclear cells additionally damaging the inflamed 
tissue 24. Several investigations have shown that many active 
constituents from medicinal plants with strong antioxidative 
activity, such as flavonoids and phenolic acids, act as anti-
inflammatory agents due to the capability to prevent neut-
rophil infiltration and neutralize free radical species in an in-
flamed area 24, 25. Regarding the high DPPH-scavenging 
capacity of the C. ligulare herb decoct, it could be 
hypothesized that its strong anti-inflammatory effect in the 
model of carrageenan-induced acute inflammation is a 
consequence of its antiradical activity. 
Moreover, observed anti-inflammatory effect could be 
substantiated by results of previous in vivo investigations 
which showed that orally administered rosmarinic and chlo-
rogenic acids, phenolics preliminary identified in investiga-
ted C. ligulare decoctions, reduce oedema in the same ani-
mal model of inflammation 26, 27. 
 
Gastroprotective activity 
 
Absolute ethanol is noxious for the stomach and is often 
used as a model substance for induction of gastric lesions. It 
affects the gastric mucosa topically and disrupts its barrier 
causing significant microvascular changes including rapid 
and strong vasoconstriction accompanied by rapid and vigo-
rous arterial dilation. As a consequence, ischemia followed 
by reperfusion occurs with formation of oxygen free radicals 
which additionally disturb gastric mucosa barrier 28–30. It has 
been demonstrated that oxygen-derived free radicals are 
directly involved in this process because their removing sti-
mulates healing of gastric lesions induced by ethanol 31. 
As in the case of acute inflammatory response, substances 
with antioxidant properties (e.g. phenolic compounds like flavo-
noids and phenolic acids), may produce protective effects aga-
inst the ulcerogenic action of absolute ethanol 32–36. Since the de-
coction of C. ligulare herb, tested in this study, showed high 
free-radical scavenging activity it could be suggested that not 
only its anti-inflammatory effect but also the gastroprotective 
one, might just in part be the consequence of this anti-radical 
activity of phenolic compounds, the main active substances of 
the extract, as responsible for producing such effects 37. 
Conclusion 
The results of the present study clearly suggested that 
the aqueous extracts of C. ligulare herb produced very strong 
DPPH-radical scavenging activity, as well as significant anti-
inflammatory and gastroprotective effects in experimental 
models of acute inflammation and acute stress-ulcer, 
respectively, in the rat. Both anti-inflammatory and anti-
ulcer effects of the extract tested were close to those of the 
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reference drugs, indomethacin and ranitidine, respectively, 
and might be a consequence of its high antioxidant activity. 
These results justify the traditional use of C. ligulare 
herb decoctions, but further phytochemical and pharmacolo-
gical investigations are warranted. 
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